Know Labs raises $3.445M in underwritten public offering of 13.25M units at $0.26/unit

USBC, Inc.

Offering of 13,250,000 units, each consisting of one share of common stock and one warrant (exercise price $0.26).
Gross proceeds of $3.445M; underwriters' over-allotment partially exercised for 1,987,500 warrants.
Net proceeds to fund product development, clinical studies, IP, and working capital.
Offering closed on August 9, 2024; Benchmark and Boustead acted as joint book-runners.
Warrants exercisable at $0.26 per share; Representative options granted at same price.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.